These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27419007)

  • 1. Dynamics of naturally acquired antibody against Haemophilus influenzae type a capsular polysaccharide in a Canadian Aboriginal population.
    Konini A; Nix E; Ulanova M; Moghadas SM
    Prev Med Rep; 2016 Jun; 3():145-50. PubMed ID: 27419007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada.
    Nix EB; Williams K; Cox AD; St Michael F; Romero-Steiner S; Schmidt DS; McCready WG; Ulanova M
    Emerg Infect Dis; 2015 Feb; 21(2):273-9. PubMed ID: 25626129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of IgG and IgM antibodies to Haemophilus influenzae type a in Canadian children.
    Huska B; Kubinec C; Sadarangani M; Ulanova M;
    Vaccine; 2022 Feb; 40(8):1128-1134. PubMed ID: 35078664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
    Nix EB; Choi J; Anthes C; Gaultier GN; Thorgrimson J; Cox AD; Tsang RSW; McCready WG; Boreham D; Ulanova M
    PLoS One; 2018; 13(8):e0201282. PubMed ID: 30110339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural immunity against Haemophilus influenzae type a and B-cell subpopulations in adult patients with severe chronic kidney disease.
    Gaultier GN; McCready W; Ulanova M
    Vaccine; 2019 Jun; 37(28):3677-3684. PubMed ID: 31122854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the impact of vaccination on curtailing Haemophilus influenzae serotype 'a'.
    Konini A; Moghadas SM
    J Theor Biol; 2015 Dec; 387():101-10. PubMed ID: 26453974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of a potential vaccine candidate for Haemophilus influenzae serotype 'a'.
    Shoukat A; Van Exan R; Moghadas SM
    Vaccine; 2018 Mar; 36(12):1681-1688. PubMed ID: 29459062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally acquired antibody against Haemophilus influenzae type a in pediatric saliva.
    Cabrera A; Nix EB; Hickman R; Zlosnik JEA; Ulanova M; Sadarangani M
    J Immunol Methods; 2022 Aug; 507():113306. PubMed ID: 35705121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of invasive
    Ulanova M; Tsang RSW; Nix EB; Kelly L; Shuel M; Lance B;
    Can J Microbiol; 2023 Jun; 69(6):219-227. PubMed ID: 36753721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaboration on a public health-driven vaccine initiative.
    Desai S; Tsang R; St Laurent M; Cox A
    Can Commun Dis Rep; 2014 Oct; 40(17):365-368. PubMed ID: 29769865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001.
    McConnell A; Tan B; Scheifele D; Halperin S; Vaudry W; Law B; Embree J;
    Pediatr Infect Dis J; 2007 Nov; 26(11):1025-31. PubMed ID: 17984810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuing surveillance of invasive
    Cerqueira A; Byce S; Tsang RSW; Jamieson FB; Kus JV; Ulanova M
    Can J Microbiol; 2019 Nov; 65(11):805-813. PubMed ID: 31242396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of Antibodies Against Haemophilus influenzae Serotype a in Alaska Before and After the Emergence of Invasive Infections.
    McClure M; Miernyk K; Bruden D; Rudolph K; Hennessy TW; Bruce MG; Nolen LD
    J Infect Dis; 2021 Feb; 223(2):326-332. PubMed ID: 32594132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.
    Eton V; Schroeter A; Kelly L; Kirlew M; Tsang RSW; Ulanova M
    Int J Infect Dis; 2017 Dec; 65():27-33. PubMed ID: 28951105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing epidemiology of invasive Haemophilus influenzae disease: Emergence and global presence of serotype a strains that may require a new vaccine for control.
    Tsang RSW; Ulanova M
    Vaccine; 2017 Jul; 35(33):4270-4275. PubMed ID: 28666758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum bactericidal antibody assays for Haemophilus influenzae serotype a.
    Rouphael NG; Satola S; Farley MM; Rudolph K; Schmidt DS; Gomez-de-León P; Robbins JB; Schneerson R; Carlone GM; Romero-Steiner S
    Clin Vaccine Immunol; 2011 Feb; 18(2):243-7. PubMed ID: 21177919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential susceptibility of invasive Haemophilus influenzae serotype a and serotype b to ampicillin and other commonly prescribed antibiotics.
    Shuel M; Whyte K; Drew T; Wylie J; Lefebvre B; Hoang L; Tsang RS
    Lett Appl Microbiol; 2014 Aug; 59(2):193-9. PubMed ID: 24712310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus influenzae serotype a as a cause of serious invasive infections.
    Ulanova M; Tsang RSW
    Lancet Infect Dis; 2014 Jan; 14(1):70-82. PubMed ID: 24268829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory characterization of invasive Haemophilus influenzae isolates from Nunavut, Canada, 2000-2012.
    Tsang RS; Li YA; Mullen A; Baikie M; Whyte K; Shuel M; Tyrrell G; Rotondo JA; Desai S; Spika J
    Int J Circumpolar Health; 2016; 75():29798. PubMed ID: 26765260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody against Haemophilus influenzae protein D in patients with chronic conditions causing secondary immunodeficiency.
    Hawdon N; Biman B; McCready W; Brigden M; Malik S; Vergidis D; Kisselgoff O; Ulanova M
    Vaccine; 2012 Feb; 30(7):1235-8. PubMed ID: 22230580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.